Obesity Trial, Recruiting NCT04087655 Sponsor: Florida State University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT04087655
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any race, sex, or socioeconomic background may be considered.
  • Women who have not yet reached menopause may be eligible.
  • Women who are currently using a combined estrogen and progestin hormonal contraceptive (such as the pill, a skin patch, or a vaginal ring) may be eligible.
  • People who have been at a stable weight for the past 6 months and do not do regular purposeful exercise may be eligible.
  • People who have been diagnosed with Metabolic Syndrome (a cluster of health conditions that raise the risk of heart disease and diabetes) may be eligible.
  • To meet the Metabolic Syndrome requirement, a person must have at least three of the following: a large waist measurement (over 40 inches for men, over 35 inches for women); high fasting blood triglycerides (above 150 mg/dL); low "good" (HDL) cholesterol (below 40 mg/dL for men or below 50 mg/dL for women); blood pressure above 130/85 mmHg; or high fasting blood sugar (above 110 mg/dL) or a specific blood sugar level recorded two hours after a sugar drink (140–200 mg/dL).

Who may not be able to join:

  • People who already do regular endurance exercise (more than 20 minutes per day, more than one day per week) may not be eligible.
  • Women who are pregnant or breastfeeding, or who have not had regular menstrual cycles over the past year, may not be eligible.
  • People taking medications that may affect blood flow or circulation may not be eligible.
  • People taking anti-inflammatory medications (such as ibuprofen or naproxen) or antidepressants known as serotonin reuptake inhibitors (SSRIs) may not be eligible.
  • People who currently smoke or use chewing tobacco may not be eligible.
  • People with diabetes (fasting blood sugar above 125 mg/dL) may not be eligible.
  • People with high blood pressure above 160/95 mmHg may not be eligible.
  • People with heart failure, chest pain (angina), or poor circulation in the limbs may not be eligible.
  • People whose heart test (ECG) shows serious irregular heartbeats or signs of reduced blood flow to the heart at rest or during exercise may not be eligible.
  • People with chronic infections, stroke-related paralysis, advanced Parkinson's Disease, severe rheumatoid arthritis, or serious bone or joint problems that would prevent them from exercising may not be eligible.
  • People who have been taking antioxidant, herbal, or vitamin supplements within the two weeks before the study begins may not be eligible.
  • People who consume caffeine on the day of any experiment session may not be eligible.
  • People whose weight changes by more than 5% during the training program may not be able to continue in the trial.
  • People whose attendance at exercise sessions falls below 90% of the required sessions or total exercise time may not be able to continue in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert C Hickner, PhD, Florida State University

Phone: 850-644-1375

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Florida State University
Registry
ClinicalTrials.gov
Start date
20 November 2019
Est. completion
19 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reactive oxygen species (ROS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov